|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Potential association of long noncoding RNA HA117 with tetralogy of Fallot显示文摘Tetralogy of Fallot(TOF)is a congenital heart disease characterized by abnormal cardiomyocyte differentiation in the right ventricular outflow tract(RVOT),and HA117 is a novel long noncoding RNA(lncRNA)with anti-differentiation roles.To investigate the potential association of HA117 with TOF,we collected 84 RVOT tissues from patients with TOF.We determined the expression of HA117 in RVOT samples from TOF patients and collected clinical data to conduct a cross-sectional and short-term follow-up study.McGoon ratio,Nakata index,and left ventricular end-diastolic volume index(LVEDVI)were negatively correlated with the expression of HA117 based on subgroup analysis,correlation analysis and logistic regression analysis.Additionally,cardiopulmonary bypass(CPB)time and ICU stay were longer in patients with higher expression of HA117 than in patients with lower expression of HA117.Furthermore,percentage improvement in SPO2 was significantly reduced in patients with increased HA117 expression at 6 months after surgery.Our results suggested that the increased expression of the novel lncRNA HA117 is a risk factor for unfavorable McGoon ratio,Nakata index and LVEDVI in TOF patients.Additionally,an increased expression of HA117 might lead to adverse short-term outcomes in TOF patients. | Quan Wang Zhili Wang Chun Wu Zhengxia Pan Li Xiang Hang Liu Xin Jin Kerong Tong Shulei Fan Xianqing Jin | 2018 | Genes & Diseases2018，5，2： | 5 |
| 2 | Functional membrane separators for next-generation high-energy rechargeable batteries显示文摘The membrane separator is a key component in a liquid-electrolyte battery for electrically separating the cathode and the anode, meanwhile ensuring ionic transport between them. Besides these basic requirements, endowing the separator with specific beneficial functions is now being paid great attention because it provides an important alternative approach for the development of batteries, particularly next-generation high-energy rechargeable batteries. Herein, functional separators are overviewed based on four key criteria of next-generation high-energy rechargeable batteries: stable,safe, smart and sustainable(4 S). That is, the applied membrane materials and the corresponding functioning mechanisms of the 4 S separators are reviewed. Functional separators with selective permeability have been applied to retard unwanted migration of the specific species(e.g. polysulfide anions in Li-S batteries) from one electrode to the other in order to achieve stable cycling operation. The covered battery types are Li-S, room-temperature Na-S, Li-organic, organic redox-flow(RF) and Li-air batteries. Safe, smart and sustainable separators are then described in sequence following the first criterion of stable cycling. In the final section, key challenges and potential opportunities in the development of 4 S separators are discussed. | Yuede Pan Shulei Chou Hua Kun Liu Shi Xue Dou | 2017 | National Science Review2017，4，6： | 4 |
| 3 | Delay-constrained sleeping mechanism for energy saving in cache-aided ultra-dense network显示文摘We investigate an energy-saving sleeping mechanism in a cache-aided ultra-dense network(UDN)with delay constraints. As in existing works, we consider the video and file contents of the UDN. The video contents are cached at and delivered by a small-cell base-station(sBS). The cache-aided sBS cooperates with a macro-cell base-station(mBS) to service the file contents. The optimal sleeping strategy that conserves energy under the delay constraint is formulated as an energy-consumption minimization problem under the network stability condition with a guaranteed delay constraint. To find its solution, the minimization problem is transformed into a joint optimization problem of energy consumption and delay by the Lyapunov technique.A delay-constrained sleeping algorithm is proposed, and its effectiveness is confirmed by the numerical results of a simulation study. A tradeoff between energy consumption and delay, achieved by adjusting the weighting factor in the cache-aided UDN, is also demonstrated. | Pei LI Shulei GONG Shen GAO Yaoyue HU Zhiwen PAN Xiaohu YOU | 2019 | Science China(Information Sciences)2019，62，8： | 1 |
| 4 | High-throughput screening and evaluation of repurposed drugs targeting the SARS-CoV-2 main protease显示文摘Dear editor,To date,a number of clinically approved drugs have been evaluated for potential to treat coronavirus disease 2019(COVID-19),such as lopinavir/ritonavir,hydroxychloroquine,cobicistat,and darunavir.Some of these drugs have been proven to be effective in vitro;however,clinical trials showed that none of these compounds led to a significant improvement in symptoms or length of hospitalization.Thus,it is essential and more reliable to start from a defined target to ide ntify can didate drugs. | Yan Li Jinyong Zhang Zilei Duan Ning Wang Xiangcheng Sun Yanjing Zhang Li Fu Kaiyun Liu Yongjun Yang Shulei Pan Yun Shi Hao Zeng Gang Guo Ren Lai Quanming Zou | 2021 | Signal Transduction and Targeted Therapy2021，6，10： | 0 |
| 5 | Biosynthesis and Immunological Evaluation of a Dual-Antigen Nanoconjugate Vaccine Against Brucella melitensis显示文摘Brucellosis,caused by Brucella,is one of the most common zoonosis.However,there is still no vaccine for human use.Although some live attenuated vaccines have been approved for animals,the protection effect is not ideal.In this study,we developed a dual-antigen nanoconjugate vaccine containing both polysaccharide and protein antigens against Brucella.First,the antigenic polysaccharide was covalently coupled to the outer membrane protein Omp19 using protein glycan coupling technology,and then it was successfully loaded on a nano-carrier through the SpyTag/SpyCatcher system.After confirming the efficient immune activation and safety performance of the dual-antigen nanoconjugate vaccine,the potent serum antibody response against the two antigens and remarkable protective effect in non-lethal and lethal Brucella infection models were further demonstrated through different routes of administration.These results indicated that the dual-antigen nanoconjugate vaccine enhanced both T helper 1 cell(Th1)and Th2 immune responses and protected mice from Brucella infection.Furthermore,we found that this protective effect was maintained for at least 18 weeks.To our knowledge,this is the first Brucella vaccine bearing diverse antigens,including a protein and polysaccharide,on a single nanoparticle.Thus,we also present an attractive technology for co-delivery of different types of antigens using a strategy applicable to other vaccines against infectious diseases. | Jing Huang Yufei Wang Kangfeng Wang Shulei Li Peng Sun Yan Guo Jiankai Liu Ruifu Yang Ming Zeng Chao Pan Hengliang Wang Li Zhu | 2023 | Engineering2023，，10： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员